Amicus Therapeutics (FOLD) Tops Q1 EPS by 4c ; Provides Outlook
Tweet
Share
E-mail
Get Alerts FOLD Hot Sheet
Price: $14.49 --0%
Financial Fact:
Restructuring charges: 11K
Today's EPS Names:
RCBC, GASS, YSG, More
Financial Fact:
Restructuring charges: 11K
Today's EPS Names:
RCBC, GASS, YSG, More
Join SI Premium – FREE
Amicus Therapeutics (NASDAQ: FOLD) reported Q1 EPS of ($0.02), $0.04 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $110.4 million versus the consensus estimate of $112.39 million.
Guidance
Total Revenue Growth - 25% to 30%
For earnings history and earnings-related data on Amicus Therapeutics (FOLD) click here.
| 25% to 30% |
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barrick Mining said to delay IPO of American gold business to 2027
- Argan (AGX) Tops Q2 EPS by 110c
- Chargepoint Holdings Inc. (CHPT) Tops Q2 EPS by 25c, Beats on Revenue
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
